Clinical Trial Update: A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10) [Phase 2]

View source ↗

Summary

This clinical trial update notes that a Phase 2 study of DZD8586 in combination therapy for chronic lymphocytic leukemia and small lymphocytic lymphoma is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• DZD8586

Snippet

Sponsor: Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Conditions: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING